Qiao Changping opened a folder, took out a document and handed it to Qin Feng,
"Currently, the research center in Jinling has launched two more cardiovascular drugs centered around 'Jing Xin Dan', targeting thrombosis and atherosclerosis.
The impact was significant right after they hit the market, and with the endorsement and channels of the four major pharmaceutical companies, it can be said to have sparked a nearly revolutionary bloodbath.
Our market share for cardiovascular oral medications has already exceeded 30%, and it's estimated that by the end of this year, this share will reach at least 85%."
Listening to Qiao Changping, Qin Feng took a sip of his drink and nodded.
Daqin Pharmaceutical has made a name for itself in the pharmaceutical industry with its first shot, an unmatched momentum.
Moreover, its background makes others fearful!
